Primary Record
Matrine
- In stock
- 1,501 g
- Purity
- 99.6 %
- CAS
- 519-02-8
Compound Identifiers & Properties
- CAS
- 519-02-8
- PubChem CID
- 91466
- SMILES
- C1C[C@@H]2[C@H]3CCCN4[C@H]3[C@@H](CCC4)CN2C(=O)C1
- Canonical SMILES
- O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@@H](CN12)[C@@H]34
Names & Synonyms
- Matrine
- (+)-Matrine
- Matridin-15-one
- 519-02-8
- Sophoridine
- Sophocarpidine
- alpha-Matrine
- Vegard
- Allomatrine
- Lupanidine
- Oxymatrine
- Matrinium
- .alpha.-Matrine
- cis-Neomatrine
- Alpha Matrine
- trans-Neomatrine
- Matrene, (+)-
- Matrine CRS
- Ku Shen Jian
- Ex Sophporae Radix
- Matrine (Standard)
- (+)-Martrine
- Matrine, food grade
- Matridin-15-one;
- [?]one
- RefChem:55556
- C15H24N2O
- MATRINE [MI]
- Matrine ((+)-Matrine)
- MATRINE [WHO-DD]
- UNII-N390W430AC
- AC1L3M4P
- CHEBI:6700
- N390W430AC
- MFCD00210527
- SCHEMBL177907
- DTXSID00274188
- CHEMBL204860
- NSC 146051
- NSC-146051
- Thieno[2,3-c]pyridin-3-amine
- CTK1H0283
- HY-N0164R
- BRN 0085851
- DTXCID70820575
- HMS3884F13
- HMS6019G05
- NSC-318810
- AMY25701
- BCP08193
- CID91466
- HY-N0164
- ZINC2083329
- (+)-Matrine, 519-02-8
- ANW-43480
- BDBM50249581
- C15-H24-N2-O
- CM0087
- Matridin-15-one; Vegard; -Matrine
- MFCD02735434
- MSK000575
- NSC146051
- s2322
- Matridin-15-one;Vegard;alpha-Matrine
- AKOS007930266
- ACN-035478
- CCG-208589
- CS-1601
- EBC-466111
- FM65961
- KS-5203
- Matrine 100 microg/mL in Acetonitrile
- RL03912
- RTR-031399
- NCGC00346593-01
- AK164135
- AN-45507
- J10.210E
- LS-89363
- O723
- SY016076
- (7aS,13aR,13bR,13cS)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one
- TR-031399
- FT-0603438
- FT-0628171
- FT-0696735
- FT-0698746
- FT-0776718
- M2120
- N1836
- NS00066991
- 5-24-02-00301 (Beilstein Handbook Reference)
- J1.983.255D
- J1.983.256B
- 19M028
- C10774
- A846751
- AA-504/21004001
- AL-466/21199007
- AO-228/21245001
- (1R,2R,9S,17S)-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadecan-6-one
- (41S,7aS,13aR,13bR)-Dodecahydro-1H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10(41H)-one
- 7,13-diazatetracyclo(7.7.1.02,7.013,17)heptadecan-6-one
- 1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aS,13aR,13bR,13cS)-
- 83148-91-8
- (1R,2R,9S,17S)-7,13-diazatetracyclo(7.7.1.02,7.013,17)heptadecan-6-one
- (1R,2R,9S,17S)-7,13-diazatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadecan-6-one
- (4(1)S,7aS,13aR,13bR)-dodecahydro-1H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10(4(1)H)-one
- (41S,7aS,13aR,13bR)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one
- (4S,7aS,9R,13aR,13bR,13cS)-2,3,6,7,7a,12,13,13a,13b,13c-Decahydro-1H,5H,8H-dipyrido[2,1-f:3 ,2 ,1 -ij][1,6]naphthyridine-10(11H)-one
- (4S,7aS,9S,13aR,13bR,13cS)-2,3,6,7,7a,12,13,13a,13b,13c-Decahydro-1H,5H,8H-dipyrido[2,1-f:3 ,2 ,1 -ij][1,6]naphthyridine-10(11H)-one
- (7aalpha,13abeta,13balpha,13calpha)-2,3,6,7,7a,12,13,13a,13b,13c-Decahydro-1H,5H,8H-dipyrido[2,1-f:3 ,2 ,1 -ij][1,6]naphthyridine-10(11H)-one
- (7aalpha,13aR,13balpha,13calpha)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3 ,2 ,1 -ij][1,6]naphthyridine-10-one
- (7aS,13aR,13bS,13cS)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3,2,1-ij][1,6]naphthyridin-10-one
- 1,2,3,4,5,6,6aalpha,7,10,11,11abeta,11balpha-Dodecahydro-11calphaH-3a,7a-diaza-3aH-benzo[de]anthracene-8(9H)-one
- 16837-52-8
- 1H,5H,10H-DIPYRIDO(2,1-F:3',2',1'-IJ)(1,6)NAPHTHYRIDIN-10-ONE, DODECAHYDRO-, (7AS,13AR,13BR,13CS)-
- 1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aS,13aR,13bR,13cS)-; Matridin-15-one; Matrine (6CI,7CI,8CI); (+)-Matrine; (7aS,13aR,13bR,13cS)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one; NSC 146051; NSC 318810; Vegard; a-Matrine
- 2,6-diamino-5-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl)oxy-1H-pyrimidin-4-one
- 641-39-4